Gabriëla Wright - Concepedia

Concepedia

Author

Gabriëla Wright

Moffitt Cancer Center ORCID

Also Known As

G Wright, G. Wright, Gabriela M Wright, Gabriela M. Wright, Gabriela Wright, Gabriëla Wright, Kimack, Nancee, Ozato, Keiko, Wright, G, Wright, Gabriela

61

Publications

1.3K

Citations

17

H-Index

48

Concepts

All Affiliations

Moffitt Cancer Center University of South Florida Molecular Oncology (United States)University of North Carolina at Chapel Hill

GW

About

Gabriëla Wright is an author at Moffitt Cancer Center specializing in medicine, cell biology, and cancer research.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	13	13	1.1K
2	Cell Biology	10	10	916
3	Immunology	6	6	369
4	Pharmacology	4	4	239
5	Pathology	2	2	172

Gabriëla Wright

×

18

Publications

1.3K

Citations

17

H-Index

	Year	Citations
Role of Stat3 in Regulating p53 Expression and Function Guilian Niu, Kenneth L. Wright, Yihong Ma, Molecular and Cellular Biology Cancer ResearchSignaling PathwayCell RegulationStat3-induced InhibitionRegulating P53 Expression	2005	395
Myc represses miR-15a/miR-16-1 expression through recruitment of HDAC3 in mantle cell and other non-Hodgkin B-cell lymphomas X Zhang, X Chen, Jianhong Lin, Oncogene Tumor BiologyLymphoid NeoplasiaMedicineMantle CellMir-15a/mir-16-1 Expression	2011	153
Proteome-wide Profiling of Clinical PARP Inhibitors Reveals Compound-Specific Secondary Targets Claire E. Knezevic, Gabriëla Wright, Lily L. Remsing Rix, Cell chemical biology Drug TargetMedicineBiomarker TargetProteomicsPathway Analysis	2016	100
Tipifarnib and Bortezomib Are Synergistic and Overcome Cell Adhesion–Mediated Drug Resistance in Multiple Myeloma and Acute Myeloid Leukemia Niranjan Yanamandra, Nandita M. Colaco, Nancy Parquet, Clinical Cancer Research	2006	94
GSK3 Alpha and Beta Are New Functionally Relevant Targets of Tivantinib in Lung Cancer Cells Lily L. Remsing Rix, Brent M. Kuenzi, Yunting Luo, ACS Chemical Biology Chemoprevention StrategyImmunotherapeuticsCancer BiologyNovel Tivantinib TargetsReceptor Tyrosine Kinase	2013	89
Positive Regulatory Domain I Binding Factor 1 Silences Class II Transactivator Expression in Multiple Myeloma Cells Nilanjan Ghosh, Ildikó Győry, Gabriëla Wright, Journal of Biological Chemistry	2001	69
Dual Targeting of WEE1 and PLK1 by AZD1775 Elicits Single Agent Cellular Anticancer Activity Gabriëla Wright, Volha A. Golubeva, Lily L. Remsing Rix, ACS Chemical Biology Wee1 Tyrosine KinaseTumor BiologyWee1 Inhibitor Azd1775MedicineImmunology	2017	67
Positive Regulatory Domain I (PRDM1) and IRF8/PU.1 Counter-regulate MHC Class II Transactivator (CIITA) Expression during Dendritic Cell Maturation Matthew A. Smith, Gabriëla Wright, Jian Wu, Journal of Biological Chemistry ImmunologyImmunologic MechanismTranscriptional RegulationCell RegulationDendritic Cell Maturation	2011	56
A Novel Element and a TEF-2-like Element Activate the Major Histocompatibility Complex Class II Transactivator in B-lymphocytes Nilanjan Ghosh, Janet F. Piskurich, Gabriëla Wright, Journal of Biological Chemistry	1999	55
Critical Role of the Tumor Suppressor Tuberous Sclerosis Complex 1 in Dendritic Cell Activation of CD4 T Cells by Promoting MHC Class II Expression via IRF4 and CIITA Hongjie Pan, Thomas O’Brien, Gabriëla Wright, The Journal of Immunology Dendritic CellT-regulatory CellImmunologyImmunologic MechanismAntigen Processing	2013	55

Page 1